Top

Environmental Health and Preventive Medicine

Published in:

Open Access 01-12-2017 | Short communication

Genetic analysis of RNF213 p.R4810K variant in non-moyamoya intracranial artery stenosis/occlusion disease in a Chinese population

Authors: Tong Zhang, Congrong Guo, Xin Liao, Jian Xia, XiaoXiao Wang, Jing Deng, Junxia Yan

Published in: Environmental Health and Preventive Medicine | Issue 1/2017

Abstract

Objectives

RNF213 p.R4810K was identified as a susceptibility variant for moyamoya disease in Asia and non-moyamoya intracranial artery stenosis/occlusion disease in Japan and Korea recently. The occurrence of this variant was evaluated in patients with non-moyamoya intracranial artery stenosis/occlusion disease in China.

Methods

Two study populations were used in this study. One was recruited from the Second Hospital of Hebei Medical University from April 2015 to May 2016. The other was the archived DNA samples of intracranial artery stenosis/occlusion patients in XiangYa Hospital collected in 2014. The occurrence of RNF213 p.R4810K was investigated in a total of 715 patients with non-moyamoya intracranial artery stenosis/occlusion disease. The carrier rate of RNF213 p.R4810K in 507 normal individuals was used as control.

Results

Six of 715 patients (0.84%) with non-moyamoya intracranial artery stenosis/occlusion disease and 2 of the 507 normal controls (0.39%) had RNF213 p.R4810K variant. The carrier rate of RNF213 p.R4810K was higher in non-moyamoya intracranial artery stenosis/occlusion group than that in the normal group. However, no statistically significant association was observed (Odds ratio, 2.14; 95% confidence interval, 0.43–10.63; p = 0.56).

Conclusions

The carrier rate of RNF213 p.R4810K in Chinese non-moyamoya intracranial artery stenosis/occlusion disease patients was significantly lower than that in Korea or Japan. Genetic heterogeneity was highly indicated. Further systematic genetic epidemiology studies with emphasis on Chinese-specific genetic variants and environmental risk factors of intracranial artery stenosis/occlusion disease in larger population are needed.

Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One. 2011;6:e22542. doi:10.1371/journal.pone.0022542.CrossRefPubMedPubMedCentral

Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, et al. A genome-wide association study identifies RNF213 as the first moyamoya disease gene. J Hum Genet. 2011;56(1):34–40. doi:10.1038/jhg.2010.132.CrossRefPubMed

Wu Z, Jiang H, Zhang L, Xu X, Zhang X, Kang Z, et al. Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population. PLoS One. 2012;7:e48179. doi:10.1371/journal.pone.0048179.CrossRefPubMedPubMedCentral

Miyawaki S, Imai H, Takayanagi S, Mukasa A, Nakatomi H, Saito N. Identification of a genetic variant common to moyamoya disease and intracranial major artery stenosis/occlusion. Stroke. 2012;43(12):3371–4. doi:10.1161/STROKEAHA.112.663864.CrossRefPubMed

Liu W, Hitomi T, Kobayashi H, Harada KH, Koizumi A. Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations. Neurol Med Chir (Tokyo). 2012;52(5):299–303.CrossRef

Miyawaki S, Imai H, Shimizu M, Yagi S, Ono H, Mukasa A, et al. Genetic variant RNF213 c.14576G > A in various phenotypes of intracranial major artery stenosis/occlusion. Stroke. 2013;44(10):2894–7. doi:10.1161/STROKEAHA.113.002477.CrossRefPubMed

Cecchi AC, Guo D, Ren Z, Flynn K, Santos-Cortez RL, Leal SM, et al. RNF213 rare variants in an ethnically diverse population with moyamoya disease. Stroke. 2014;45(11):3200–7. doi:10.1161/STROKEAHA.114.006244.CrossRefPubMedPubMedCentral

Moteki Y, Onda H, Kasuya H, Yoneyama T, Okada Y, Hirota K, et al. Systematic validation of RNF213 coding variants in Japanese patients with moyamoya disease. J Am Heart Assoc. 2015;4(5). doi:10.1161/JAHA.115.001862.

Bang OY, Ryoo S, Kim SJ, Yoon CH, Cha J, Yeon JY, et al. Adult moyamoya disease: a burden of intracranial stenosis in East Asians? PLoS One. 2015;10(6):e0130663. doi:10.1371/journal.pone.0130663.CrossRefPubMedPubMedCentral

10.

Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I, et al. Homozygous c.14576G > A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology. 2012;78(11):803–10. doi:10.1212/WNL.0b013e318249f71f.CrossRefPubMed

11.

Miyawaki S, Imai H, Shimizu M, Yagi S, Ono H, Nakatomi H, et al. Genetic analysis of RNF213 c.14576G > A variant in nonatherosclerotic quasi-moyamoya disease. J Stroke Cerebrovasc Dis. 2015;24(5):1075–9. doi:10.1016/j.jstrokecerebrovasdis.2015.01.005.CrossRefPubMed

12.

Kim YJ, Lee JK, Ahn SH, Kim BJ, Kang DW, Kim JS, et al. Nonatheroscleotic isolated middle cerebral artery disease may be early manifestation of moyamoya disease. Stroke. 2016;47(9):2229–35. doi:10.1161/STROKEAHA.116.012751.CrossRefPubMed

13.

Bang OY, Chung JW, Cha J, Lee MJ, Yeon JY, Ki CS, et al. A polymorphism in RNF213 is a susceptibility gene for intracranial atherosclerosis. PLoS One. 2016;11(6):e0156607. doi:10.1371/journal.pone.0156607.CrossRefPubMedPubMedCentral

14.

Koizumi A, Kobayashi H, Liu W, Fujii Y, Senevirathna ST, Nanayakkara S, et al. P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure [J]. Environ Health Prev Med. 2013;18(2):121–9. doi:10.1007/s12199-012-0299-1.CrossRefPubMed

15.

Cao Y, Kobayashi H, Morimoto T, Kabata R, Harada KH, Koizumi A. Frequency of RNF213 p.R4810K, a susceptibility variant for moyamoya disease, and health characteristics of carriers in the Japanese population. Environ Health Prev Med. 2016;21(5):387–90. doi:10.1007/s12199-016-0549-8.CrossRefPubMed

16.

Jang MA, Shin S, Yoon JH, Ki CS. Frequency of the moyamoya-related RNF213 p.Arg4810Lys variant in 1,516 Korean individuals [J]. BMC Med Genet. 2015;16:109. doi:10.1186/s12881-015-0252-4.CrossRefPubMedPubMedCentral

17.

Wang X, Zhang Z, Liu W, Xiong Y, Sun W, Huang X, et al. Impacts and interactions of PDGFRB, MMP-3, TIMP-2, and RNF213 polymorphisms on the risk of moyamoya disease in Han Chinese human subjects. Gene. 2013;526(2):437–42. doi:10.1016/j.gene.2013.05.083.CrossRefPubMed

18.

Zhang Q, Liu Y, Zhang D, Wang R, Zhang Y, Wang S, et al. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance. J Neurosurg. 2017;126(4):1106–13. doi:10.3171/2016.2.JNS152173.

19.

Huang Y, Cheng D, Zhang J, Zhao W. Association between the rs112735431 polymorphism of the RNF213 gene and moyamoya disease: a case–control study and meta-analysis. J Clin Neurosci. 2016;32:14–8. doi:10.1016/j.jocn.2015.11.035.CrossRefPubMed

20.

Morito D, Nishikawa K, Hoseki J, Kitamura A, Kotani Y, Kiso K, et al. Moyamoya disease-associated protein mysterin/RNF213 is a novel AAA+ ATPase, which dynamically changes its oligomeric state. Sci Rep. 2014;4:4442. doi:10.1038/srep04442.CrossRefPubMedPubMedCentral

21.

Ogura T, Wilkinson AJ. AAA+ superfamily ATPases: common structure--diverse function. Genes Cells. 2001;6(7):575–97.CrossRefPubMed

22.

Geisbrecht BV, Collins CS, Reuber BE, Gould SJ. Disruption of a PEX1-PEX6 interaction is the most common cause of the neurologic disorders zellweger syndrome, neonatal adrenoleukodystrophy, and infantile refsum disease. Proc Natl Acad Sci U S A. 1998;95(15):8630–5.CrossRefPubMedPubMedCentral

23.

Reuber BE, Germain-Lee E, Collins CS, Morrell JC, Ameritunga R, Moser HW, et al. Mutations in PEX1 are the most common cause of peroxisome biogenesis disorders. Nat Genet. 1997;17(4):445–8.CrossRefPubMed

24.

Abramzon Y, Johnson JO, Scholz SW, Taylor JP, Brunetti M, Calvo A, et al. Valosin-containing protein (VCP) mutations in sporadic amyotrophic lateral sclerosis. Neurobiol Aging. 2012;33(9):2231.e1–6. doi:10.1016/j.neurobiolaging.2012.04.005.CrossRef

25.

Koizumi A, Kobayashi H, Hitomi T, Harada KH, Habu T, Youssefian S, et al. A new horizon of moyamoya disease and associated health risks explored through RNF213. Environ Health Prev Med. 2016;21(2):55–70. doi:10.1007/s12199-015-0498-7.CrossRefPubMed

26.

Caplan LR, Gorelick PB, Hier DB. Race, sex and occlusive cerebrovascular disease: a review. Stroke. 1986;17(4):648–55.CrossRefPubMed

27.

Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis, Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo). 2012;52(5):245–66.CrossRef

28.

Duan L, Bao XY, Yang WZ, Shi WC, Li DS, Zhang ZS, et al. Moyamoya disease in China: its clinical features and outcomes. Stroke. 2012;43(1):56–60. doi:10.1161/STROKEAHA.111.621300.CrossRefPubMed

Title: Genetic analysis of RNF213 p.R4810K variant in non-moyamoya intracranial artery stenosis/occlusion disease in a Chinese population
Authors: Tong Zhang
Congrong Guo
Xin Liao
Jian Xia
XiaoXiao Wang
Jing Deng
Junxia Yan
Publication date: 01-12-2017
Publisher: BioMed Central
Published in: Environmental Health and Preventive Medicine / Issue 1/2017
Print ISSN: 1342-078X
Electronic ISSN: 1347-4715
DOI: https://doi.org/10.1186/s12199-017-0649-0

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Genetic analysis of RNF213 p.R4810K variant in non-moyamoya intracranial artery stenosis/occlusion disease in a Chinese population

Abstract

Objectives

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Objectives

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2017

Association between high and low ambient temperature and out-of-hospital cardiac arrest with cardiac etiology in Japan: a case-crossover study

Alteration in plasma free amino acid levels and its association with gout

Associations between the duration of active commuting to school and academic achievement in rural Chilean adolescents

Anorexia nervosa, depression and suicidal thoughts among Chinese adolescents: a national school-based cross-sectional study

Potential predictors of susceptibility to occupational stress in Japanese novice nurses - a pilot study

Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan